| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $45.6M | -2.9% |
| SG&A Expense | $20.7M | -4.0% |
| Operating Income | -$66.4M | +3.3% |
| Income Tax | $0 | — |
| Net Income | -$63.2M | -2.9% |
| EPS (Basic) | -$2.19 | +12.4% |
| EPS (Diluted) | -$2.19 | +12.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.5M | +4.9% |
| Current Assets | $177.7M | +4.9% |
| Total Assets | $184.7M | +4.0% |
| Current Liabilities | $11.3M | +13.2% |
| Long-term Debt | $16.2M | +57.7% |
| Total Liabilities | $33.5M | +28.6% |
| Stockholders' Equity | $151.1M | -0.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.8M | -9.2% |
| Capital Expenditures | $24K | -98.8% |
| Investing Cash Flow | -$24K | +98.8% |
| Financing Cash Flow | $60.1M | -55.7% |
| Free Cash Flow | -$51.8M | -4.6% |